# A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

> **NCT00914290** · PHASE2 · COMPLETED · sponsor: **Impax Laboratories, LLC** · enrollment: 23 (actual)

## Conditions studied

- Spasticity
- Multiple Sclerosis

## Interventions

- **DRUG:** IPX056
- **DRUG:** Baclofen IR
- **DRUG:** Placebo IPX056
- **DRUG:** Placebo IR

## Key facts

- **NCT ID:** NCT00914290
- **Lead sponsor:** Impax Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914290, "A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00914290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*